Discovery of 4,6-pyrimidinediamine derivatives as novel dual EGFR/FGFR inhibitors aimed EGFR/FGFR1-positive NSCLC - Concepedia

Concepedia

Publication | Open Access

Discovery of 4,6-pyrimidinediamine derivatives as novel dual EGFR/FGFR inhibitors aimed EGFR/FGFR1-positive NSCLC

DOI Full Paper Access

27

Citations

13

References

2019

Year

Zixin Xie, Kaiqi Wu, Yuexuan Wang, Yaqian Pan, Bo Chen, Donghua Cheng, Suwei Pan, Taoning Guo, Xuze Du, Longcheng Fang,

European Journal of Medicinal Chemistry

Egfr/fgfr1-positive NsclcMedicinal ChemistryMedicineNatural SciencesPharmacotherapyAnti-cancer Agent4,6-Pyrimidinediamine DerivativesDrug DevelopmentChemical BiologyPharmacologyRadiation OncologyDrug Discovery

References

	Year	Citations

Page 1

Page 1